Tackling Disparities in Oncology Requires Action as Well as Research
In this interview, Dr. Andrea Silber discusses how the COVID-19 pandemic has exacerbated disparities that already existed within oncology care, and she said the effects of these disparities on patients are very real and direct.Source: Pharmacy Times
Breast cancer care in U.S. territories lags behind care in states
Older women residing in the U.S territories are less likely to receive recommended or timely care for breast cancer compared with similar women residing in the continental United States, according to Yale researchers. Their findings were published in the March issue of Health Affairs.
Yale Cancer Center receives $1 million grant to address cancer disparities
Researchers at Yale Cancer Center (YCC) have been awarded a $1 million grant by the Bristol-Myers Squibb Foundation (BSMF) to address health care disparities in cancer care and support. The grant will fund the Cancer Disparities Firewall project, a multilevel intervention that focuses on patient and system level factors that contribute to cancer disparities in the YCC/New Haven, Connecticut area. The project will target lung, breast, colorectal, and prostate cancer.
Yale Study: Minority Breast Cancer Patients Less Likely To Have Genetic Test
A genetic test that helps doctors determine how best to treat breast cancer—and whether chemotherapy is likely to help—is significantly more likely to be administered to white women than blacks or Hispanics, a Yale study has found.Source: Connecticut Health I-Team
Racial Disparities in Genetic Testing of Women With Breast Cancer
MedicalResearch.com Interview with: Cary P. Gross, MD Section of General Internal Medicine Yale University School of Medicine New Haven, CT MedicalResearch.com: What is the background for this study? What are the main findings? Response: Prior work has demonstrated racial and socioeconomic disparities in breast cancer diagnosis, treatment, and outcomes. As the oncology field has progressed over the past decade, the use of genetic testing to guide treatment decisions is one of the most exciting new developments.Source: Medical Research
Yale Study Published in JNCCN Uncovers Racial Disparities in Treatment of Women with Breast Cancer
In a simple definition, cancer is a disease of the cells, which is caused by gene mutations. For a proportion of patients, including women with hormone receptor positive (HR+) breast cancer, gene expression profiling has a substantial impact on treatment decision-making by determining which patients might—or might not—respond to particular treatment options.
Understanding Breast Cancer Disparities in the United States
At a recent Yale Cancer Center Grand Rounds lecture, Dr. Beth Jones, Research Scientist, Epidemiology and Public Health, discussed the disparities that exist in breast cancer in the United States, focusing mainly on Hispanic and Latino women. By the year 2050 Hispanic/Latinos will represent close to 1/3 of the U.S. population.
Yale Global Health Leadership Initiative secures grant to reduce inequities in sepsis outcomes and care
The Yale Global Health Leadership Initiative has been awarded a highly competitive research grant exceeding $1 million to reduce inequities in sepsis care and outcomes among African American/Black and Latinx communities.
Study provides deeper insights on the health impacts of utility shutoffs
Connecticut residents who struggle to pay their energy bills often suffer from physical and mental health issues as a result. That is one of many findings in a new study of energy insecurity based on interviews with 22 residents of varying ages and races from around the state. The study was a joint undertaking by the Yale School of Public Health, Yale School of the Environment, Vermont Law and Graduate School, and Operation Fuel, an energy-assistance nonprofit.Source: Energy News Network
Total Joint Arthroplasty Direct-to-Consumer Advertising by Medical Device Companies Lacks Patient Diversity
Obese and African American populations suffer from higher incidence of hip and knee osteoarthritis, yet African Americans are less likely to undergo total hip and knee arthroplasty (TJA). Patient interest in TJA is a necessary first step for surgery. Medical device company direct-to-consumer advertising for TJA represents 1 potential factor driving disparities in utilization. The authors analyze demographics of models represented in medical device company direct-to-consumer TJA advertisements to understand whether advertisement content correlates with the population in need.
Physicians Need to Move Beyond Checklists to Address Disparities in Arthroplasty Care
One of the many challenges that orthopaedic surgeons face today is evaluating a patient as a whole by looking beyond a checklist that determines eligibility for surgery. When orthopaedic surgeons decline to perform joint replacements on patients with comorbidities, are underrepresented populations being disproportionately impacted? The data show the answer is yes.
Yale VAMOS Program Provides Holistic Vascular Care
The Vascular Medicine OutcomeS (VAMOS) program at Yale University, an integral program supported by the Yale New Haven Health’s Heart and Vascular Center and Center for Musculoskeletal Care, includes a global team of interventional cardiologists, vascular surgeons, podiatrists, radiologists, allied health professionals, and outcomes researchers committed to transforming how PAD is diagnosed and treated, and how patients access care.
Good News, Bad News for Older Survivors of Acute MI
A new 25-year study reveals that mortality after an acute myocardial infarction (AMI) and repeat events are coming down for all older Americans. But it also highlights the need for more work, especially efforts to root out healthcare inequities.Source: Medscape